Mathias Haag
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A Machine Vision-Guided Microphysiological Platform With Automated Microfluidics Enables Longitudinal Biomarker Monitoring and Emulation of Translationally Relevant Exposure Scenarios.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 03, 2025
Klebsiella pneumoniae contributes to altered cytotoxicity of thiopurines in vitro: Possible implications of biotransformation and bacterial metabolism.
Journal: British journal of pharmacology
Published: March 13, 2025
The liver proteome of individuals with a natural UGT2B17 complete deficiency.
Journal: Scientific reports
Published: November 21, 2024
Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes.
Journal: Annual review of pharmacology and toxicology
Published: August 16, 2023
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation.
Journal: Pharmacological research
Published: August 14, 2023
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.
Journal: Cell
Published: May 23, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers.
Journal: Frontiers in pharmacology
Published: December 20, 2022
Performance comparison of narrow-bore and capillary liquid-chromatography for non-targeted metabolomics profiling by HILIC-QTOF-MS.
Journal: Talanta
Published: November 25, 2022
Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical Trial.
Journal: International journal of molecular sciences
Published: October 21, 2022
Last Updated: 09/26/2026